Cello Health Launches FutureScope Market Predictor

UK-based Cello's Health division has launched a product called FutureScope, to help clients understand likely future market dynamics and customer needs within each therapy area.

In March, Cello brought together its five health-related businesses under the Cello Health brand, offering three distinct capabilities: Insight; Consulting; and Communications.

FutureScope will develop scenarios based on scientific and clinical trends, economic and political drivers, and likely competitive entrants. These scenarios will then be used to characterize future market needs from the perspective of payers, patients, prescribers and providers, with the ultimate goal being to identify future opportunities and prioritise them according to their potential for commercial success.

Steve Mather (pictured) of Cello Health Consulting comments: 'Understanding likely future market dynamics and stakeholder needs is essential to ensuring commercial success. FutureScope helps life science companies reduce some of the uncertainty around early product development and determine which opportunities are the most viable and most commercially attractive to pursue.'

Web site: www.cellohealth.com .